Derniers essais

EudraCT Number: 2004-002782-20

Sponsor Protocol Number: H3E-MC-JMHH

Start Date: 2005-04-15

Sponsor Name: Eli Lilly and Company Limited

Full Title: A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal Cancer

Medical condition: platinum sensitive recurrent ovarian or primary peritoneal cancer

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed) SE (Completed)

Trial results: View results

EudraCT Number: 2004-004824-11

Sponsor Protocol Number: ELBE-2005

Start Date: 2005-04-15

Sponsor Name: Universitätshautklinik Kiel

Full Title: Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, intra-patient, double-blind (right/left arm) ...

Medical condition: Atopic Dermatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004681-33

Sponsor Protocol Number: D1447C00001

Start Date: 2005-04-15

Sponsor Name: AstraZeneca AB

Full Title: An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600...

Medical condition: Bipolar Depression

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) EE (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2004-005164-25

Sponsor Protocol Number: 04.09

Start Date: 2005-04-14

Sponsor Name: Odense University Hospital

Full Title: Phase II study of thalidomide in combination with temozolomide in metastatic malignant melanoma with brain metastases

Medical condition: Advanced metastic malignant melanoma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000859-15

Sponsor Protocol Number: ML 18542

Start Date: 2005-04-14

Sponsor Name: ROCHE

Full Title: Randomized prospective study comparing dexamethasone and dexamethasone plus rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP) in adults.

Medical condition: Front-line treatment of adult ITP

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10021245		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-003929-27

Sponsor Protocol Number: STRADIVARIUS

Start Date: 2005-04-14

Sponsor Name: SANOFI-SYNTHELABO

Full Title: Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg od, for inhibition of atherosclerosis progression assessed by IVUS (IntraVascular UltraSo...

Medical condition: Inhibition of coronary atherosclerosis progression in overweight patients with a cluster of risk factors.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-002560-17

Sponsor Protocol Number: 25543

Start Date: 2005-04-14

Sponsor Name: NV Organon

Full Title: A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizop...

Medical condition: Schizophrenia with predominant, persistent negative symptoms

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10039626		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed) CZ (Completed) GB (Completed) IT (Completed) ES (Completed) HU (Completed)

Trial results: View results

EudraCT Number: 2004-005166-20

Sponsor Protocol Number: 04.10

Start Date: 2005-04-14

Sponsor Name: Odense University Hospital

Full Title: Phase II study of first-line therapy with Thalidomide in combination with Peg-introna and decrescendo IL-2 in patients with metastatic malignant melanoma

Medical condition: Metastatic malignant melanoma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000366-39

Sponsor Protocol Number: Astra-003

Start Date: 2005-04-14

Sponsor Name: Inamed Research GmbH & Co. KG

Full Title: Effect of Oxis on the Efficacy of Mucociliary Clearance in Patients with COPD

Medical condition: Chronic obstructive pulmonary disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004053-26

Sponsor Protocol Number: SEEG 0001

Start Date: 2005-04-14

Sponsor Name: Birthe Pedersen

Full Title: An explorative use open-label, multi-center, randomized trial studying the safety and efficacy of levetiracetam (500 mg/day to 3000 mg/day) and valproate (600 mg/day to 3000 mg/day) as monotherapy ...

Medical condition: Newly diagnosed epilepsy patients are over 65 years. In this age group more cases are symptomatic and it is apparently another disorder than epilepsy in adults. Epilepsy in the elderly is easier to...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) DK (Completed)

Trial results: (No results available)

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue